metFORMIN ER Tablets, 500 mg, Rx, Packaged and labeled as metFORMIN Immediate Release (IR), Repackaged By: Shamrock Medical Solutions Lewis Center, Ohio, Mfr: Amneal/Interpharm, Hauppauge, NY NDC 53746-178-01
Published July 30, 2014 · Recall initiated: September 27, 2011
Summary
FDA records drug Class I recall D-1448-2014, published July 30, 2014 and initiated September 27, 2011. Recalling firm: Shamrock Medical Solutions Group LLC; Status: Terminated; Reported quantity: 88/5 mg tablets; Lot: Lot #: 00267J Use By: 7/28/2012 NDC: 53746-178-01. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Label Mix up; product labeled did not indicated Extended Release
What to do
Voluntary: Firm initiated · Telephone
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Shamrock Medical Solutions Group LLC
- Distributor
- Product was shipped to the following states: CO, MA, OH, TX & WY.
- Lot
- Lot #: 00267J Use By: 7/28/2012 NDC: 53746-178-01
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADocusate Calcium Softgel Capsules, 240 mg, OTC, packaged and labeled to contain Docusate Sodium 240mg,July 30, 2014
- FDAOxycodone HCl Oral Concentrate, 20 mg/mL, Rx (C-II) Packaged and labeled as Morphine Sulfate 20 mg/mL, Mfg:July 30, 2014
- FDATaztia XT (Diltiazem HCl) Capsules, 120 mg, Rx, Packaged and labeled as Thiamine. Re-Packaged By: ShamrockJuly 30, 2014
- FDASulfamethoxazole and Trimethoprim Tablets, 800 mg/160 mg, DOUBLE STRENGTH, Rx, packaged and labeled to containJuly 30, 2014
- FDAPramipexole Dihydrochloride Tablets, 0.5 mg, Rx, packaged and labeled to contain Nebivolol tablets, RepackagedJuly 30, 2014
- FDAOrphenadrine Citrate Extended Release Tablets, 100 mg a)100-count bottle, (NDC 0185-0022-01) b) 1000-countJuly 30, 2014
Questions about this recall
Was metFORMIN ER Tablets, 500 mg, Rx, Packaged and labeled as metFORMIN Immediate Release (IR), Repackaged By: Shamrock Medical Solutions Lewis Center, Ohio, Mfr: Amneal/Interpharm, Hauppauge, NY NDC 53746-178-01 recalled?
Yes. FDA published recall D-1448-2014 on July 30, 2014. Reported hazard: Labeling: Label Mix up; product labeled did not indicated Extended Release
What should I do if I have this product?
Voluntary: Firm initiated · Telephone